Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Husa

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Epidemiologie, Mikrobiologie, Imunologie : Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne|October 15, 2013
[Dengue fever cases in Czech workers returning from the Maldives]Milan Trojánek, Dora Tomíčková, Hana Roháčová, et al.
The Lancet. Respiratory Medicine|January 18, 2017
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trialFrancisco M Marty, Joan Vidal-Puigserver, Carol Clark, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2012
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patientsSamuel S Lee, Stuart K Roberts, Hanna Berak, et al.
International Journal of Public Health|October 11, 2020
Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristicsLubomír Skladaný, Marian Oltman, Soňa Fraňková, et al.
Journal of Hepatology|May 24, 2003
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersEugene R Schiff, Jules L Dienstag, Selim Karayalcin, et al.
Gastroenterology|December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis BScott Fung, Peter Kwan, Milotka Fabri, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Archives of Internal Medicine|January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BSeng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
Scientific Reports|May 13, 2021
COVID-19's natural course among ambulatory monitored outpatientsBarbora Weinbergerova, Jiri Mayer, Stepan Hrabovsky, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Epidemiologie, Mikrobiologie, Imunologie : Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne|October 15, 2013
[Dengue fever cases in Czech workers returning from the Maldives]Milan Trojánek, Dora Tomíčková, Hana Roháčová, et al.
The Lancet. Respiratory Medicine|January 18, 2017
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trialFrancisco M Marty, Joan Vidal-Puigserver, Carol Clark, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2012
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patientsSamuel S Lee, Stuart K Roberts, Hanna Berak, et al.
International Journal of Public Health|October 11, 2020
Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristicsLubomír Skladaný, Marian Oltman, Soňa Fraňková, et al.
Journal of Hepatology|May 24, 2003
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersEugene R Schiff, Jules L Dienstag, Selim Karayalcin, et al.
Gastroenterology|December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis BScott Fung, Peter Kwan, Milotka Fabri, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Archives of Internal Medicine|January 13, 2006
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BSeng Gee Lim, Tay Meng Ng, Nelson Kung, et al.
Scientific Reports|May 13, 2021
COVID-19's natural course among ambulatory monitored outpatientsBarbora Weinbergerova, Jiri Mayer, Stepan Hrabovsky, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Pageof 9